Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

PureTech Secures U.S. and EU Orphan Designations for Deupirfenidone (LYT-100) in IPF

U.S. Food and Drug Administration (FDA) and European Commission have granted Orphan Drug Designation to deupirfenidone (LYT-100) for the treatment of idiopathic pulmonary fibrosis (IPF), a rare, progressive, and fatal lung disease. Deupirfenidone...

ENFLONSIA™ (clesrovimab) shows positive new results in infants and children under 2 at increased risk of severe RSV disease across two seasons, Merck reports

MSD outside of the United States and Canada, announced positive second RSV season findings from the Phase 3 SMART trial (MK-1654-007) (NCT04938830) evaluating the safety, efficacy and pharmacokinetics of ENFLONSIA™ (clesrovimab) in infants and...

Gantry-less upright proton therapy for lung cancer re-irradiation shows first-ever prospective clinical results, announced by P-Cure

completed treatment without interruption. At three months post-treatment, local control within the re-irradiated volume was 100%, with complete metabolic response, partial response, or stable disease observed in all evaluable patients. Acute...

To strengthen global AI, data strategy, evidence synthesis, and economic modelling capabilities, Precision AQ expands its senior leadership team

Precision AQ, a global commercialisation partner built to guide life science innovators through commercial complexity, announced the appointment of two new leaders who will accelerate the company's international growth and enhance delivery of...

New ECCO data demonstrate that subcutaneous infliximab (Remsima™ SC) recaptures and maintains disease control following a drug holiday

Crohn’s disease (CD) and ulcerative colitis (UC) patients with sustained efficacy, safety, and persistence through to Week 102. The data will be presented as a poster presentation at the 21st Congress of the European Crohn’s and Colitis...

Breakthrough in Zika Virus Drug Discovery Reported by IRBM

IRBM, a leader in early drug discovery research, has announced a major scientific breakthrough with the discovery of a novel and potent allosteric inhibitor targeting the Zika virus (ZIKV) protease (NS2B-NS3). The findings, published in Nature...

A Breakthrough Study Confirms HYD LLC's 30-Year Research on Deuterium Modulation in Cancer Gene Expression.

levels (as low as 40 ppm) suppressed genes associated with proliferation and drug resistance (e.g., MYCN, ETS2, ABCB1), while high deuterium environments (300 ppm) upregulated multiple oncogenic and survival pathways (EGFR, CTNNB1, STAT3, CD44)....

FDA Grants KORU Medical Systems 510(k) Clearance for RYSTIGGO® Delivery via FreedomEDGE® Infusion System

affects communication between nerves and muscles.¹ RYSTIGGO® is administered as a weekly infusion of 3mL-6mL of drug over 15-30 minutes for 6 weeks, with subsequent treatment cycles based on clinical evaluation.¹ “With this new FDA clearance, we...

Tonix Pharmaceuticals presented Phase 3 RESILIENT data on TONMYA™ (cyclobenzaprine HCl sublingual tablets) at the 2026 Non-Opioid Pain Therapeutics Summit

Corp. a fully integrated, commercial biotechnology company, presented data on TONMYA™, which was investigated as TNX-102 SL, at the 2026 Non-Opioid Pain Therapeutics Summit, on January 29, 2026, in Boston, Massachusetts. A copy of the Company's...

China approves Libevitug, first-in-class therapy for hepatitis D

virus infection in adults with or without compensated cirrhosis. Libevitug is a human monoclonal antibody targeting the PreS1 domain of the large envelope protein of hepatitis B virus (HBV) and hepatitis D virus (HDV), thereby blocking viral entry...

DARZALEX FASPRO® quadruplet approved in U.S. for transplant-ineligible multiple myeloma patients

lenalidomide and dexamethasone (VRd) in NDMM patients who were ineligible for ASCT or deferred ASCT as initial therapy.1 Today's milestone follows approval for D-VRd for the treatment of patients who are newly diagnosed with multiple myeloma and...

Correction — Privo Technologies

Privo Technologies, Inc. announced the successful completion of its Phase 1/2 clinical evaluation of PRV211, a first-in-class intraoperative chemotherapy patch for head and neck cancer patients. The study demonstrated excellent safety outcomes...

HanchorBio Partners with WuXi Biologics to Advance Next-Generation Fusion Protein Pipeline

modalities, aiming to activate both innate and adaptive immune pathways to overcome the current challenges of anti-PD1/L1 immunotherapies. The FBDB™ platform has successfully delivered proof-of-concept data in several in vivo tumor animal models....

CoreAge Rx broadens GLP-1 access in support of New Year weight loss initiatives

pharmacy specializing in personalized medication services, announced a strategic New Year's expansion of its compounded GLP-1 weight management program. The expansion provides increased access to compounded tirzepatide and semaglutide, perfectly...

OCuSOFT Inc. introduces Retaine® Omega Forté™, a liquid supplement designed to deliver superior nutritional support in the management of dry eye

OCuSOFT Inc. a privately-held eye care pharma company recognized as developing the first eyelid hygiene cleansing agent, proudly announces the launch of Retaine® Omega Forté™, a highly purified omega-3 nutritional supplement formulated to provide...

BIOCORNEUM® announces the availability of its new dual-action bruise system designed to enhance post-procedure recovery

BIOCORNEUM®, the leading brand in professional scar and skin recovery, announced the immediate availability of its new Bruise Care System. The innovative dual-approach regimen is designed to help patients prepare for and recover more quickly from...

MTF Biologics and Kolosis BIO introduce Summit Matrix™, expanding solutions for orthopedic and spinal surgeries

MTF Biologics, a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, transplantation, and research, and Kolosis BIO (Kolosis), a premier provider of orthobiologic solutions, announced the launch of...

First National Campaign Launched by Trauma Intervention Programs (TIP)

For more than forty years, Trauma Intervention Programs (TIP) has stood beside individuals and families during their most devastating moments, providing immediate, on-scene emotional first aid in the aftermath of tragedy. TIP recently announced...

Lansinoh® Launched NaturalWave® Double Electric Breast Pump Featuring Exclusive Flutter Technology for Increased Milk Output

with user-centric design to maximize output and comfort: Hospital-Strength Power: Provides hospital-grade suction with 12 adjustable strength levels and 2-phase technology. Baby-Inspired Pumping Styles: Features three distinct pumping styles and a...

Align Technology Supports Children and Teens With 30 Invisalign® Treatments via Smiles4Canada Program

treatment for 30 eligible patients through CFAO’s Smiles4Canada program, a public health goodwill program founded in 2016 to put a smile, both figuratively and literally, on a young person with significant orthodontic needs, whose family does not...